24/7 Wall St. Biotech Report: Short-Selling And Splits (AMGN)(CELG)
Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor. The short interest in Amgen (AMGN) dropped 22% and Calgene (CELG) fell 20%. Alexion Pharmaceuticals (ALXN) split its shares 2-for-1 stock. The company’s stock has…
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Short sellers moved out of biotech stocks in the latest period according to Biohealth Investor.
The short interest in Amgen (AMGN) dropped 22% and Calgene (CELG) fell 20%.
Alexion Pharmaceuticals (ALXN) split its shares 2-for-1 stock.
The company’s stock has done well as this was in the mid-$70’s in mid-July and shares put in a new 52-week and multi-year high this week with shares briefly trading above $95.00.
Contact [email protected] for any questions or corrections.
